187 related articles for article (PubMed ID: 38112209)
1. Sweet Syndrome: Clinical Presentation, Malignancy Association, Autoinflammatory Disorders and Treatment Response in a Cohort of 93 Patients with Long-term Follow-up.
Gil-Lianes J; Luque-Luna M; Alamon-Reig F; Bosch-Amate X; Serra-Garcia L; Mascaró JM
Acta Derm Venereol; 2023 Dec; 103():adv18284. PubMed ID: 38112209
[TBL] [Abstract][Full Text] [Related]
2. Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center.
Nelson CA; Noe MH; McMahon CM; Gowda A; Wu B; Ashchyan HJ; Perl AE; James WD; Micheletti RG; Rosenbach M
J Am Acad Dermatol; 2018 Feb; 78(2):303-309.e4. PubMed ID: 29107342
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Sweet syndrome in patients with or without malignancy.
Jung EH; Park JH; Hwan Kim K; Kim JS; Sil Choi I; Byun JM; Koh Y; Shin DY; Hong J; Yoon SS; Park H; Kim I
Ann Hematol; 2022 Jul; 101(7):1499-1508. PubMed ID: 35482090
[TBL] [Abstract][Full Text] [Related]
4. Sweet syndrome associated with malignancies: A retrospective analysis of 25 patients from West China hospital.
Dan H; Yanmei L; Yue X; Xian J
Dermatol Ther; 2020 Jul; 33(4):e13588. PubMed ID: 32410345
[TBL] [Abstract][Full Text] [Related]
5. Xanthomatized Neutrophilic Dermatosis in a Patient With Myelodysplastic Syndrome.
Ferris GJ; Fabbro S; Gru A; Kaffenberger J
Am J Dermatopathol; 2017 May; 39(5):384-387. PubMed ID: 27759696
[TBL] [Abstract][Full Text] [Related]
6. From Histiocytoid Sweet Syndrome to Myelodysplasia Cutis: History and Perspectives.
Vignon-Pennamen MD; Battistella M
Dermatol Clin; 2024 Apr; 42(2):209-217. PubMed ID: 38423682
[TBL] [Abstract][Full Text] [Related]
7. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients.
Rochet NM; Chavan RN; Cappel MA; Wada DA; Gibson LE
J Am Acad Dermatol; 2013 Oct; 69(4):557-64. PubMed ID: 23891394
[TBL] [Abstract][Full Text] [Related]
8. VEXAS syndrome: A dermatological perspective.
Nguyen JK; Routledge D; van Der Weyden C; Blombery P; Angel CM; Johnson D; Goh MS; Lee A
Australas J Dermatol; 2022 Nov; 63(4):488-492. PubMed ID: 36197697
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia and myelodysplastic syndrome-associated Sweet syndrome: A comparative multicenter retrospective study of 39 patients.
Merlant M; Lepelletier C; Battistella M; Vignon-Pennamen MD; Duriez P; Moguelet P; Brunet-Possenti F; Bagot M; Chasset F; Bouaziz JD
J Am Acad Dermatol; 2021 Mar; 84(3):838-840. PubMed ID: 33065169
[No Abstract] [Full Text] [Related]
10. Sweet's syndrome associated with hematological malignancies.
Maller B; Bigness A; Moiño D; Greene J
Leuk Res; 2020 Dec; 99():106461. PubMed ID: 33099235
[TBL] [Abstract][Full Text] [Related]
11. Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome.
Martinelli S; Rigolin GM; Leo G; Gafà R; Lista E; Cibien F; Sofritti O; Daghia G; Cavazzini F; Cuneo A
Int J Hematol; 2014; 99(5):663-7. PubMed ID: 24554168
[TBL] [Abstract][Full Text] [Related]
12. Histiocytoid Sweet syndrome and cutaneous polyarteritis nodosa secondary to myelodysplastic syndrome.
Pinal-Fernandez I; Ferrer Fabrega B; Ramentol Sintas M; Solans Laque R
Int J Rheum Dis; 2013 Dec; 16(6):777-9. PubMed ID: 24382288
[No Abstract] [Full Text] [Related]
13. Histiocytoid Sweet Syndrome Is More Frequently Associated With Myelodysplastic Syndromes Than the Classical Neutrophilic Variant: A Comparative Series of 62 Patients.
Ghoufi L; Ortonne N; Ingen-Housz-Oro S; Barhoumi W; Begon E; Haioun C; Pautas C; Beckerich F; Robin C; Wolkenstein P; Cordonnier C; Chosidow O; Toma A
Medicine (Baltimore); 2016 Apr; 95(15):e3033. PubMed ID: 27082547
[TBL] [Abstract][Full Text] [Related]
14. Neutrophilic Dermatosis in Myelodysplastic Syndrome and Chronic Active Hepatitis C.
Sharma R; Johnson RH; Heidari A; Malerich M; Stull WR; Cobos E
J Investig Med High Impact Case Rep; 2021; 9():23247096211037458. PubMed ID: 34334014
[TBL] [Abstract][Full Text] [Related]
15. Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases.
Vignon-Pennamen MD; Juillard C; Rybojad M; Wallach D; Daniel MT; Morel P; Verola O; Janin A
Arch Dermatol; 2006 Sep; 142(9):1170-6. PubMed ID: 16983004
[TBL] [Abstract][Full Text] [Related]
16. Histiocytoid Sweet syndrome harboring an isocitrate dehydrogenase 1 mutation: A case report and retrospective analysis of 29 cases of histiocytoid Sweet syndrome.
Libby TJ; Fleming K; Amin B
J Cutan Pathol; 2019 Apr; 46(4):290-292. PubMed ID: 30632174
[TBL] [Abstract][Full Text] [Related]
17. Chronic relapsing remitting Sweet syndrome--a harbinger of myelodysplastic syndrome.
Kulasekararaj AG; Kordasti S; Basu T; Salisbury JR; Mufti GJ; du Vivier AW
Br J Haematol; 2015 Sep; 170(5):649-56. PubMed ID: 25962438
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature.
Chan MP; Duncan LM; Nazarian RM
J Am Acad Dermatol; 2013 Jun; 68(6):1006-15. PubMed ID: 23399459
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous histiocytoid Sweet syndrome and its relationship to hematological diseases.
Bush JW; Wick MR
J Cutan Pathol; 2016 Apr; 43(4):394-9. PubMed ID: 26694973
[TBL] [Abstract][Full Text] [Related]
20. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
